Inoue Tomio, Itoh Satsuki, Wakisaka Satoshi, Ogawa Satoshi, Saito Mitsuru, Morimoto Toshifumi
Department of Oral Physiology, Showa University School of Dentistry, Tokyo 142-8555, Japan.
Brain Res. 2002 Nov 8;954(2):202-11. doi: 10.1016/s0006-8993(02)03286-9.
Intracellular recordings were obtained from rat presumed jaw-closing motoneurons in slice preparations to investigate the involvement of the serotonin(7) (5-HT(7)) receptors in serotonergic inhibition of the postspike medium-duration afterhyperpolarization (mAHP) and enhancement of the afterdepolarization (ADP). 5-HT-induced suppression of the mAHP and enhancement of the ADP were mimicked by application of the 5-HT(1A/7) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and antagonized by the 5-HT(2/6/7) receptor antagonist clozapine, whereas the 5-HT(2) receptor agonist alpha-methyl-5-hydroxytryptamine (alpha-methyl-5-HT) did not affect the mAHP and ADP. 8-OH-DPAT-induced attenuation of the mAHP and enhancement of the ADP were also antagonized by clozapine and another 5-HT(2/6/7) receptor antagonist ritanserin, whereas the 5-HT(1A) receptor antagonist pindolol failed to block the 8-OH-DPAT-induced effects on the mAHP and ADP. 8-OH-DPAT-induced suppression of the mAHP and enhancement of the ADP were also antagonized by a protein kinase A (PKA) inhibitor H89, whereas 8-OH-DPAT could inhibit the mAHP and enhance the ADP in the presence of a protein kinase C (PKC) inhibitor chelerythrine. The 8-OH-DPAT-induced suppression of the mAHP was enhanced under raised Ca(2+) and this enhancement was reduced by chelerythrine. It is suggested that the 5-HT(7) receptors are involved in 5-HT-induced attenuation of the mAHP and enhancement of the ADP through activation of PKA, and the attenuation of mAHP through the 5-HT(7) receptors is enhanced under raised Ca(2+) by PKC activation.
在脑片制备中,从大鼠假定的闭口运动神经元进行细胞内记录,以研究5-羟色胺(7)(5-HT(7))受体在5-羟色胺能抑制峰后中期时程超极化(mAHP)和增强去极化后电位(ADP)中的作用。应用5-HT(1A/7)受体激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)可模拟5-HT诱导的mAHP抑制和ADP增强,而5-HT(2/6/7)受体拮抗剂氯氮平可拮抗这种作用,而5-HT(2)受体激动剂α-甲基-5-羟色胺(α-甲基-5-HT)对mAHP和ADP无影响。氯氮平和另一种5-HT(2/6/7)受体拮抗剂利坦色林也可拮抗8-OH-DPAT诱导的mAHP衰减和ADP增强,而5-HT(1A)受体拮抗剂吲哚洛尔未能阻断8-OH-DPAT对mAHP和ADP的诱导作用。蛋白激酶A(PKA)抑制剂H89也可拮抗8-OH-DPAT诱导的mAHP抑制和ADP增强,而在蛋白激酶C(PKC)抑制剂白屈菜红碱存在的情况下,8-OH-DPAT仍可抑制mAHP并增强ADP。在升高的细胞外钙离子浓度([Ca(2+)]o)下,8-OH-DPAT诱导的mAHP抑制作用增强,而白屈菜红碱可减弱这种增强作用。提示5-HT(7)受体通过激活PKA参与5-HT诱导的mAHP衰减和ADP增强,并且在升高的[Ca(2+)]o下,PKC激活可增强通过5-HT(7)受体介导的mAHP衰减。